CPhI Worldwide
Real Chemistry Deepens German Market Expertise with Appointment of Dirk Poschenrieder as Managing Director, Germany
Senior hire strengthens Real Chemistry’s ability to help healthcare clients connect global strategy to nuanced needs for in-market execution
Future of MHRA uncertain amid Brexit-fuelled shake up
Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions
MHRA outlines two-year delivery plan with ‘patient first’ focus
New delivery plan also outlines strategy for UK regulatory body following Brexit
The Brexit clock is counting down and time is running out
What businesses need to know about post-Brexit immigration
Germany’s coronavirus infections climb but deaths remain low
Experts debate ‘anomaly’ as other countries record higher death rates
It’s Brexit day – now comes the really hard stuff
Months of trade negotiations between UK and EU lie ahead
Boris Johnson to unveil ‘talent visa’ for high-flying scientists
Global Talent visa due to come into effect on 20 February
UK biotech funding falls 40% between 2018 and 2019
Drop attributed to global uncertainty and Neil Woodford scandal
EU group calls for ‘targeted actions’ to mitigate impact of Brexit
Committee wants to ensure safe supply of drugs and medical devices
Thousands of EU staffers have left NHS since 2016, says Lib Dems
Figures come from information provided by 50 NHS hospital trusts
UK is a leader in early clinical research but falls in later study stages, says ABPI
The UK faces challenges to stay competitive in clinical research globally
NHS leader warns politicians not to ‘weaponise’ the health service
Top exec challenges main parties to provide credible solutions to big issues